Key result
Intercurrent treatment discontinuations may introduce potential bias in efficacy estimates for antithrombotic therapy clinical trials.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This invited editorial discusses potential bias in efficacy estimates due to intercurrent treatment discontinuations in clinical trials, specifically in the context of antithrombotic therapy.
This invited editorial refers to ‘Potential bias in efficacy estimates due to intercurrent treatment discontinuations’, by B. Redfors et al., https://doi.o
No takes yet. Share an insight, caveat, or question.
Curcio et al. (2026) studied this question. Intercurrent treatment discontinuations may introduce potential bias in efficacy estimates for antithrombotic therapy clinical trials.
Synapse has enriched 10 related papers. Consider them for comparative context: